Biography

Dr. Amalia Gastaldelli is the research director of the Cardiometabolic Risk Laboratory at the Institute of Clinical Physiology (IFC) of CNR of Pisa, Italy, adjunct professor at the Division of Diabetes of University of Texas Health Science Center, in San Antonio, TX, USA (since 2006) and at the Scuola Superiore S. Anna in Pisa (since 2017). Her research includes the study of alterations in glucose and lipid metabolism, insulin resistance and ectopic fat accumulation. She has more than 25 years experience in leading national and international scientific projects investigating the pathophysiological mechanisms leading to metabolic diseases including obesity, non alcoholic fatty liver disease (NAFLD) and type 2 diabetes. She was the principal investigator in many international projects most of which on liver metabolism, like the project “Effect of Exenatide on Brain, Adipose Tissue, Pancreas, and Liver Function”, the EU-FP7 FLIP (Fatty Liver Inhibition of Progression), the H2020 EPOS (Elucidating Pathways of Steatohepatitis), one H2020 Marie Curie ETN program for training of international students (FOIE GRAS) and two Marie Curie RISE for the staff exchange (MAST4HEALTH and mtFOIEGRAS) and the IMI2-LITMUS on the discovery of biomarkers of NAFLD, the IMI2-SOPHIA for stratificatoion of obesity. She is also collaborating with many institutions in Europe and United States, participating to local grants as foreign partner. She has published more than 400 original articles and book chapters with >30000 citations and an H index >87 in Scopus.

From 2010 to 2020 she was the Director of the European Chapter of the American College of Nutrition (ECACN), member of board of directors of American College of Nutrition (ACN).
In 2011 she initiated and is currently the Chair of the MASLD Study Group, which provides a joint forum for diabetologists and hepatologists to explore the diagnosis, pathogenesis and treatment of MASLD and MASH. Since 2018 she is the Chair of the European Group for the study of Insulin Resistance (EGIR).
She has been a member of the EASL-EASD-EASO committees for the “Clinical Practice Guidelines for the management of MASLD” (published in 2016 and 2024).

She is also associate editor of Journal of Hepatology (since 2024), associate editor of Diabetes Care (since 2022), associate editor and member of the publication committee of the Journal of American Nutrition Association (previous Journal of American College of Nutrition). Member of the Editorial board of 5 international journals and reviewer for more the 50 international peer review journals.
She has been an invited speaker in more than 100 national and international congresses and recognized among the top Italian women scientists for biomedical sciences.